{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T19:13:31Z","timestamp":1785266011373,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Malignant mesothelioma (MESO) is a highly aggressive cancer with poor prognosis. Epithelial\u2013mesenchymal transition (EMT) is a critical process in malignancies involved in tumor angiogenesis, progression, invasion and metastasis, immunosuppressive microenvironment and therapy resistance. However, there is a lack of specific biomarkers to identify EMT in MESO. Biphasic MESO with dual phenotypes could be an optimal model to study EMT process. Using a powerful EMTome to investigate EMT gene signature, we identified a panel of EMT genes <jats:italic>COL5A2, ITGAV, SPARC<\/jats:italic> and <jats:italic>ACTA2<\/jats:italic> in MESO. In combination with TCGA database, Timer2.0 and other resources, we observed that overexpression of these emerging genes is positively correlated with immunosuppressive infiltration, and an unfavorable factor to patient survival in MESO. The expression of these genes was confirmed in our patients and human cell lines. Our findings suggest that these genes may be novel targets for therapeutics and prognosis in MESO and other types of cancers.<\/jats:p>","DOI":"10.1038\/s41598-022-04973-x","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T11:02:56Z","timestamp":1642590176000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["A panel of emerging EMT genes identified in malignant mesothelioma"],"prefix":"10.1038","volume":"12","author":[{"given":"Licun","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaheer","family":"Amjad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sendurai","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"de Perrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,19]]},"reference":[{"key":"4973_CR1","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1038\/s41467-021-21798-w","volume":"12","author":"M Zhang","year":"2021","unstructured":"Zhang, M. et al. Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment. Nat. Commun. 12, 1751. https:\/\/doi.org\/10.1038\/s41467-021-21798-w (2021).","journal-title":"Nat. Commun."},{"issue":"5","key":"4973_CR2","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/j.jtcvs.2019.10.122","volume":"159","author":"M de Perrot","year":"2020","unstructured":"de Perrot, M. et al. Prognostic influence of tumor microenvironment after hypofractionated radiation and surgery for mesothelioma. J. Thorac. Cardiovasc. Surg. 159(5), 2082-2091.e1. https:\/\/doi.org\/10.1016\/j.jtcvs.2019.10.122 (2020) (Epub 2019 Nov 13. PMID: 31866087).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"6","key":"4973_CR3","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri, R. & Weinberg, R. A. The basics of epithelial\u2013mesenchymal transition [published correction appears in J. Clin. Invest. 2010 May 3;120(5):1786]. J. Clin. Invest. 119(6), 1420\u20131428. https:\/\/doi.org\/10.1172\/JCI39104 (2009).","journal-title":"J. Clin. Invest."},{"issue":"6","key":"4973_CR4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","volume":"21","author":"J Yang","year":"2020","unstructured":"Yang, J. et al. EMT International Association (TEMTIA). Guidelines and definitions for research on epithelial\u2013mesenchymal transition. Nat. Rev. Mol. Cell Biol. 21(6), 341\u2013352. https:\/\/doi.org\/10.1038\/s41580-020-0237-9 (2020) (Epub 2020 Apr 16. PMID: 32300252; PMCID: PMC7250738).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"4973_CR5","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery, J. P., Acloque, H., Huang, R. Y. & Nieto, M. A. Epithelial\u2013mesenchymal transitions in development and disease. Cell 139(5), 871\u2013890. https:\/\/doi.org\/10.1016\/j.cell.2009.11.007 (2009) (PMID: 19945376).","journal-title":"Cell"},{"key":"4973_CR6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrc.2017.118","volume":"18","author":"T Brabletz","year":"2018","unstructured":"Brabletz, T. et al. EMT in cancer. Nat. Rev. Cancer 18, 128\u2013134 (2018).","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"4973_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto, M. A., Huang, R. Y., Jackson, R. A. & Thiery, J. P. EMT: 2016. Cell 166(1), 21\u201345. https:\/\/doi.org\/10.1016\/j.cell.2016.06.028 (2016) (PMID: 27368099).","journal-title":"Cell"},{"key":"4973_CR8","doi-asserted-by":"publisher","first-page":"14684","DOI":"10.1038\/ncomms14684","volume":"8","author":"M Aragona","year":"2017","unstructured":"Aragona, M. et al. Defining stem cell dynamics and migration during wound healing in mouse skin epidermis. Nat. Commun. 8, 14684 (2017).","journal-title":"Nat. Commun."},{"issue":"2020","key":"4973_CR9","doi-asserted-by":"publisher","first-page":"9148310","DOI":"10.1155\/2020\/9148310","volume":"29","author":"R Yang","year":"2020","unstructured":"Yang, R., Wang, J., Chen, X., Shi, Y. & Xie, J. Epidermal stem cells in wound healing and regeneration. Stem Cells Int. 29(2020), 9148310. https:\/\/doi.org\/10.1155\/2020\/9148310 (2020) (PMID: 32399054; PMCID: PMC7204129).","journal-title":"Stem Cells Int."},{"key":"4973_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00332-6","author":"AW Lambert","year":"2021","unstructured":"Lambert, A. W. & Weinberg, R. A. Linking EMT programmes to normal and neoplastic epithelial stem cells. Nat. Rev. Cancer https:\/\/doi.org\/10.1038\/s41568-021-00332-6 (2021) (Epub ahead of print. PMID: 33547455).","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"4973_CR11","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1084\/jem.20181827","volume":"216","author":"NM Aiello","year":"2019","unstructured":"Aiello, N. M. & Kang, Y. Context-dependent EMT programs in cancer metastasis. J. Exp. Med. 216(5), 1016\u20131026. https:\/\/doi.org\/10.1084\/jem.20181827 (2019).","journal-title":"J. Exp. Med."},{"issue":"7","key":"4973_CR12","doi-asserted-by":"publisher","first-page":"3560","DOI":"10.1172\/JCI124037","volume":"130","author":"Y Salazar","year":"2020","unstructured":"Salazar, Y. et al. Microenvironmental Th9 and Th17 lymphocytes induce metastatic spreading in lung cancer. J. Clin. Invest. 130(7), 3560\u20133575 (2020).","journal-title":"J. Clin. Invest."},{"key":"4973_CR13","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","volume":"21","author":"J Yang","year":"2020","unstructured":"Yang, J. et al. Guidelines and definitions for research on epithelial\u2013mesenchymal transition. Nat. Rev. Mol. Cell Biol. 21, 341\u2013352 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6","key":"4973_CR14","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.stem.2008.05.007","volume":"2","author":"DC Radisky","year":"2008","unstructured":"Radisky, D. C. & LaBarge, M. A. Epithelial\u2013mesenchymal transition and the stem cell phenotype. Cell Stem Cell 2(6), 511\u2013512. https:\/\/doi.org\/10.1016\/j.stem.2008.05.007 (2008) (PMID: 18522839).","journal-title":"Cell Stem Cell"},{"issue":"6","key":"4973_CR15","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.ccr.2012.09.022","volume":"22","author":"JH Tsai","year":"2012","unstructured":"Tsai, J. H., Donaher, J. L., Murphy, D. A., Chau, S. & Yang, J. Spatiotemporal regulation of epithelial\u2013mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 22(6), 725\u2013736. https:\/\/doi.org\/10.1016\/j.ccr.2012.09.022 (2012) (Epub 2012 Nov 29. PMID: 23201165; PMCID: PMC3522773).","journal-title":"Cancer Cell"},{"issue":"11","key":"4973_CR16","doi-asserted-by":"publisher","first-page":"eaax7525","DOI":"10.1126\/sciadv.aax7525","volume":"5","author":"Y Wu","year":"2019","unstructured":"Wu, Y. et al. Phospholipid remodeling is critical for stem cell pluripotency by facilitating mesenchymal-to-epithelial transition. Sci. Adv. 5(11), eaax7525. https:\/\/doi.org\/10.1126\/sciadv.aax7525 (2019).","journal-title":"Sci. Adv."},{"issue":"2","key":"4973_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.stem.2016.10.018","volume":"20","author":"M Latil","year":"2017","unstructured":"Latil, M. et al. Cell-type-specific chromatin states differentially prime squamous cell carcinoma tumor-initiating cells for epithelial to mesenchymal transition. Cell Stem Cell 20(2), 191-204.e5. https:\/\/doi.org\/10.1016\/j.stem.2016.10.018 (2017) (Epub 2016 Nov 23. PMID: 27889319; PMCID: PMC5939571).","journal-title":"Cell Stem Cell"},{"key":"4973_CR18","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-018-0040-3","volume":"556","author":"I Pastushenko","year":"2018","unstructured":"Pastushenko, I. et al. Identification of the tumour transition states occurring during EMT. Nature 556, 463\u2013468. https:\/\/doi.org\/10.1038\/s41586-018-0040-3 (2018).","journal-title":"Nature"},{"issue":"2","key":"4973_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre, A. & Weinberg, R. A. New insights into the mechanisms of epithelial\u2013mesenchymal transition and implications for cancer. Nat. Rev. Mol. Cell Biol. 20(2), 69\u201384. https:\/\/doi.org\/10.1038\/s41580-018-0080-4 (2019) (PMID: 30459476).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"4973_CR20","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1158\/1078-0432.CCR-12-1558","volume":"19","author":"LA Byers","year":"2013","unstructured":"Byers, L. A. et al. An epithelial\u2013mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clin. Cancer Res. 19(1), 279\u2013290. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-1558 (2013).","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"4973_CR21","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/dvdy.24485","volume":"247","author":"DL Gibbons","year":"2018","unstructured":"Gibbons, D. L. & Creighton, C. J. Pan-cancer survey of epithelial\u2013mesenchymal transition markers across the Cancer Genome Atlas. Dev. Dyn. 247(3), 555\u2013564. https:\/\/doi.org\/10.1002\/dvdy.24485 (2018).","journal-title":"Dev. Dyn."},{"key":"4973_CR22","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1038\/s41598-020-60707-x","volume":"10","author":"AR Jung","year":"2020","unstructured":"Jung, A. R. et al. Epithelial\u2013mesenchymal transition gene signature is associated with prognosis and tumor microenvironment in head and neck squamous cell carcinoma. Sci. Rep. 10, 3652. https:\/\/doi.org\/10.1038\/s41598-020-60707-x (2020).","journal-title":"Sci. Rep."},{"key":"4973_CR23","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41416-020-01178-9","volume":"124","author":"SV Vasaikar","year":"2021","unstructured":"Vasaikar, S. V. et al. EMTome: A resource for pan-cancer analysis of epithelial\u2013mesenchymal transition genes and signatures. Br. J. Cancer 124, 259\u2013269. https:\/\/doi.org\/10.1038\/s41416-020-01178-9 (2021).","journal-title":"Br. J. Cancer"},{"issue":"3","key":"4973_CR24","doi-asserted-by":"publisher","first-page":"924","DOI":"10.21037\/tlcr.2020.03.38","volume":"9","author":"L Brcic","year":"2020","unstructured":"Brcic, L. & Kern, I. Clinical significance of histologic subtyping of malignant pleural mesothelioma. Transl. Lung Cancer Res. 9(3), 924\u2013933. https:\/\/doi.org\/10.21037\/tlcr.2020.03.38 (2020) (PMID: 32676358; PMCID: PMC7354152).","journal-title":"Transl. Lung Cancer Res."},{"key":"4973_CR25","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/s42003-021-02430-5","volume":"4","author":"M Chan","year":"2021","unstructured":"Chan, M. et al. Blocking the GITR-GITRL pathway to overcome resistance to therapy in sarcomatoid malignant pleural mesothelioma. Commun. Biol. 4, 914. https:\/\/doi.org\/10.1038\/s42003-021-02430-5 (2021).","journal-title":"Commun. Biol."},{"issue":"1","key":"4973_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1186\/s12885-018-4354-1","volume":"18","author":"L Wu","year":"2018","unstructured":"Wu, L. et al. Putative cancer stem cells may be the key target to inhibit cancer cell repopulation between the intervals of chemoradiation in murine mesothelioma. BMC Cancer 18(1), 471. https:\/\/doi.org\/10.1186\/s12885-018-4354-1 (2018).","journal-title":"BMC Cancer"},{"issue":"2","key":"4973_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre, A. & Weinberg, R. A. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat. Rev. Mol. Cell Biol. 20(2), 69\u201384. https:\/\/doi.org\/10.1038\/s41580-018-0080-4 (2019) (PMID: 30459476).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7842","key":"4973_CR28","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41586-020-03046-1","volume":"589","author":"I Pastushenko","year":"2021","unstructured":"Pastushenko, I. et al. Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis. Nature 589(7842), 448\u2013455. https:\/\/doi.org\/10.1038\/s41586-020-03046-1 (2021) (Epub 2020 Dec 16. PMID: 33328637).","journal-title":"Nature"},{"key":"4973_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12931-020-01449-2","volume":"21","author":"M Kojima","year":"2020","unstructured":"Kojima, M. et al. Possible reversibility between epithelioid and sarcomatoid types of mesothelioma is independent of ERC\/mesothelin expression. Respir. Res. 21, 187. https:\/\/doi.org\/10.1186\/s12931-020-01449-2 (2020).","journal-title":"Respir. Res."},{"key":"4973_CR30","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41586-019-1897-5","volume":"577","author":"J Su","year":"2020","unstructured":"Su, J. et al. TGF-\u03b2 orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1. Nature 577, 566\u2013571 (2020).","journal-title":"Nature"},{"issue":"10","key":"4973_CR31","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010091","volume":"97","author":"XT Zeng","year":"2018","unstructured":"Zeng, X. T., Liu, X. P., Liu, T. Z. & Wang, X. H. The clinical significance of COL5A2 in patients with bladder cancer: A retrospective analysis of bladder cancer gene expression data. Medicine (Baltimore) 97(10), e0091. https:\/\/doi.org\/10.1097\/MD.0000000000010091 (2018) (PMID: 29517678; PMCID: PMC5882427).","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"4973_CR32","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.3390\/cancers12102948","volume":"12","author":"M Pagano","year":"2020","unstructured":"Pagano, M. et al. Mutational profile of malignant pleural mesothelioma (MPM) in the phase II RAMES study. Cancers (Basel). 12(10), 2948. https:\/\/doi.org\/10.3390\/cancers12102948 (2020) (PMID: 33065998; PMCID: PMC7601196).","journal-title":"Cancers (Basel)."},{"issue":"3","key":"4973_CR33","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ccell.2019.01.007","volume":"35","author":"J Cooper","year":"2019","unstructured":"Cooper, J. & Giancotti, F. G. Integrin signaling in cancer: Mechanotransduction, stemness, epithelial plasticity, and therapeutic resistance. Cancer Cell 35(3), 347\u2013367. https:\/\/doi.org\/10.1016\/j.ccell.2019.01.007 (2019) (PMID: 30889378; PMCID: PMC6684107).","journal-title":"Cancer Cell"},{"issue":"1","key":"4973_CR34","doi-asserted-by":"publisher","first-page":"18411","DOI":"10.1038\/s41598-020-75085-7","volume":"10","author":"H Loeser","year":"2020","unstructured":"Loeser, H. et al. Integrin alpha V (ITGAV) expression in esophageal adenocarcinoma is associated with shortened overall-survival. Sci. Rep. 10(1), 18411. https:\/\/doi.org\/10.1038\/s41598-020-75085-7 (2020) (PMID: 33110104; PMCID: PMC7591891).","journal-title":"Sci. Rep."},{"issue":"6","key":"4973_CR35","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1080\/15384047.2017.1323585","volume":"18","author":"Y Ding","year":"2017","unstructured":"Ding, Y., Pan, Y., Liu, S., Jiang, F. & Jiao, J. Elevation of MiR-9-3p suppresses the epithelial\u2013mesenchymal transition of nasopharyngeal carcinoma cells via down-regulating FN1, ITGB1 and ITGAV. Cancer Biol. Ther. 18(6), 414\u2013424. https:\/\/doi.org\/10.1080\/15384047.2017.1323585 (2017) (PMID: 28613134; PMCID: PMC5536934).","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"4973_CR36","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1186\/s12885-019-5885-9","volume":"19","author":"J Song","year":"2019","unstructured":"Song, J. et al. Epithelial\u2013mesenchymal transition markers screened in a cell-based model and validated in lung adenocarcinoma. BMC Cancer 19(1), 680. https:\/\/doi.org\/10.1186\/s12885-019-5885-9 (2019) (PMID: 31296175; PMCID: PMC6624955).","journal-title":"BMC Cancer"},{"issue":"5","key":"4973_CR37","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/bjc.2015.470","volume":"114","author":"SC Kao","year":"2016","unstructured":"Kao, S. C. et al. A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma. Br. J. Cancer. 114(5), 524\u2013531. https:\/\/doi.org\/10.1038\/bjc.2015.470 (2016) (PMID: 26889976; PMCID: PMC4782201).","journal-title":"Br. J. Cancer."},{"key":"4973_CR38","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/eye.2015.29","volume":"29","author":"D Ganatra","year":"2015","unstructured":"Ganatra, D. et al. Association of histone acetylation at the ACTA2 promoter region with epithelial mesenchymal transition of lens epithelial cells. Eye 29, 828\u2013838. https:\/\/doi.org\/10.1038\/eye.2015.29 (2015).","journal-title":"Eye"},{"issue":"4","key":"4973_CR39","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/modpathol.2017.170","volume":"31","author":"LE Rosen","year":"2018","unstructured":"Rosen, L. E. et al. Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: A multi-institutional study. Mod. Pathol. 31(4), 598\u2013606. https:\/\/doi.org\/10.1038\/modpathol.2017.170 (2018) (Epub 2018 Jan 12. PMID: 29327706).","journal-title":"Mod. Pathol."},{"issue":"2","key":"4973_CR40","doi-asserted-by":"publisher","first-page":"90","DOI":"10.5603\/ARM.2019.0015","volume":"87","author":"M Mlika","year":"2019","unstructured":"Mlika, M., Limam, M., Benzarti, A. & Mezni, F. Impact on survival of nuclear atypia in epithelioid malignant mesothelioma. Adv. Respir. Med. 87(2), 90\u201395. https:\/\/doi.org\/10.5603\/ARM.2019.0015 (2019) (PMID: 31038719).","journal-title":"Adv. Respir. Med."},{"issue":"3","key":"4973_CR41","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3892\/or.2020.7669","volume":"44","author":"Y Ohara","year":"2020","unstructured":"Ohara, Y. et al. Connective tissue growth factor produced by cancer-associated fibroblasts correlates with poor prognosis in epithelioid malignant pleural mesothelioma. Oncol. Rep. 44(3), 838\u2013848. https:\/\/doi.org\/10.3892\/or.2020.7669 (2020) (Epub 2020 Jul 3. PMID: 32705221; PMCID: PMC7388423).","journal-title":"Oncol. Rep."},{"key":"4973_CR42","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-4459","author":"M Taki","year":"2021","unstructured":"Taki, M. et al. Tumor immune microenvironment during epithelial\u2013mesenchymal transition. Clin. Cancer Res. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-4459 (2021) (Epub ahead of print. PMID: 33827891).","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"4973_CR43","doi-asserted-by":"publisher","first-page":"691","DOI":"10.4049\/jimmunol.1600458","volume":"197","author":"PJ Chockley","year":"2016","unstructured":"Chockley, P. J. & Keshamouni, V. G. Immunological consequences of epithelial\u2013mesenchymal transition in tumor progression. J. Immunol. 197(3), 691\u2013698. https:\/\/doi.org\/10.4049\/jimmunol.1600458 (2016).","journal-title":"J. Immunol."},{"issue":"6","key":"4973_CR44","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","volume":"19","author":"DG DeNardo","year":"2019","unstructured":"DeNardo, D. G. & Ruffell, B. Macrophages as regulators of tumour immunity and immunotherapy. Nat. Rev. Immunol. 19(6), 369\u2013382. https:\/\/doi.org\/10.1038\/s41577-019-0127-6 (2019) (PMID: 30718830; PMCID: PMC7339861).","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"4973_CR45","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.jtho.2016.06.021","volume":"11","author":"LA Lievense","year":"2016","unstructured":"Lievense, L. A. et al. Pleural effusion of patients with malignant mesothelioma induces macrophage-mediated T cell suppression. J. Thorac. Oncol. 11(10), 1755\u20131764. https:\/\/doi.org\/10.1016\/j.jtho.2016.06.021 (2016) (Epub 2016 Jul 12. PMID: 27418106).","journal-title":"J. Thorac. Oncol."},{"key":"4973_CR46","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.3390\/ijms22052738","volume":"22","author":"F Morani","year":"2021","unstructured":"Morani, F. et al. Identification of overexpressed genes in malignant pleural mesothelioma. Int. J. Mol. Sci. 22, 2738. https:\/\/doi.org\/10.3390\/ijms22052738 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"4973_CR47","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-21-0230","author":"A Wirawan","year":"2021","unstructured":"Wirawan, A. et al. A Novel therapeutic strategy targeting the mesenchymal phenotype of malignant pleural mesothelioma by suppressing LSD1. Mol Cancer Res. https:\/\/doi.org\/10.1158\/1541-7786.MCR-21-0230 (2021) (Epub ahead of print. PMID: 34593606).","journal-title":"Mol Cancer Res."},{"issue":"7","key":"4973_CR48","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1007\/s11626-015-9885-z","volume":"51","author":"W Blum","year":"2015","unstructured":"Blum, W. et al. Establishment of immortalized murine mesothelial cells and a novel mesothelioma cell line. In Vitro Cell Dev. Biol. Anim. 51(7), 714\u2013721 (2015).","journal-title":"In Vitro Cell Dev. Biol. Anim."},{"issue":"4","key":"4973_CR49","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.stemcr.2017.02.005","volume":"8","author":"W Blum","year":"2017","unstructured":"Blum, W. et al. Stem cell factor-based identification and functional properties of in vitro-selected subpopulations of malignant mesothelioma cells. Stem Cell Rep. 8(4), 1005\u20131017 (2017).","journal-title":"Stem Cell Rep."},{"issue":"1","key":"4973_CR50","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41416-020-01178-9","volume":"124","author":"SV Vasaikar","year":"2021","unstructured":"Vasaikar, S. V. et al. EMTome: A resource for pan-cancer analysis of epithelial\u2013mesenchymal transition genes and signatures. Br. J. Cancer. 124(1), 259\u2013269. https:\/\/doi.org\/10.1038\/s41416-020-01178-9 (2021) (PMID: 33299129; PMCID: PMC7782839).","journal-title":"Br. J. Cancer."},{"issue":"W1","key":"4973_CR51","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li, T. et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 48(W1), W509\u2013W514. https:\/\/doi.org\/10.1093\/nar\/gkaa407 (2020) (PMID: 32442275; PMCID: PMC7319575).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-04973-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-04973-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-04973-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T20:44:54Z","timestamp":1669322694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-04973-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,19]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4973"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-04973-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,19]]},"assertion":[{"value":"16 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1007"}}